(State or other jurisdiction of incorporation) | (Commission file number) | (IRS Employer Identification No.) |
N/A | ||
(Former name or former address, if changed since last report) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Cover Page |
Mar. 26, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Mar. 26, 2024 |
Entity Registrant Name | EDWARDS LIFESCIENCES CORPORATION |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 1-15525 |
Entity Tax Identification Number | 36-4316614 |
Entity Address, Address Line One | One Edwards Way |
Entity Address, City or Town | Irvine |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92614 |
City Area Code | 949 |
Local Phone Number | 250-2500 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $1.00 per share |
Trading Symbol | EW |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001099800 |
Amendment Flag | false |
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end
',K-'Q61<^(L3[ T@0Q3[Q#*_1*!8\T]K&@Z'T2'R&!#N!:1GPJTT.-5&0O
M,6,KUO8=Z.^5'&J\S&": ^9^TZ>&- (\ NLI1L*]<$)ZS _'./U8B$H2C_O0
M^$0@D$+/QR6X0<4"#W1#A: >PY&O:,#"D?2G1 )$E_VI;IXT"'L@_1BY)T>5
M"^A=,T[(^^,%PC.T0*'$,XV0MHX_=X9.!1]LYKY8+SN'!$SGPQXB
M&Z!L/OD2<%P]R5GW^QQ9=L3R57 %:HN[ Z,@"27E.D;OA:'?HZ"#"LQAAFH<
M-.#J0:ETM+.[I=GDF4@)V%@4$XD6LA$N1SZ+O4+)+B<&O)* @'D'>]8!:7ZX
M)+9C%J#BAH@]0]+1NA!G.449J_T]E;T;^MR%N0BNS\"SXR"R:GKI[Z+I8
M-)O*E_\N*@^B,MP%667S\E;),^R]7I)MELD*X@9O=O""=M"6
A/1C&2*TWN>MJG/O>SW,PNY]G(.98])H9/<'H-X/VP9IJU!_3J43N[W&)
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MW/=)#\!)OX\:"(TY)@P$OP,CFN'9O8P+W%H'1QBF!"/ !#*:1P"M"4&;X/0
M!Q$2Y'@SWYB&X[S>#=V:]T-I5TLFP%N9]\C>NAPXR5LCJZA#
M'I-H;88XR'$/ 3^2&Y;]"5